The 6th Genome Editing Therapeutics Summit

2025 had been industry-defining for the genome editing space. With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the field stood at a pivotal juncture, ready to unlock the transformative potential of both established assets, and cutting-edge breakthroughs. 

In an effort to capture this excitement, spotlight innovation and propel clinical progress, the 6th Genome Editing Therapeutics Summit addressed challenges and advancements in the application and delivery of novel gene editing technologies, including base, prime, epigenome editing and more, this forum serves as your lens into the future of genome editing.   

Showcasing both clinical advances and cutting-edge technologies from Metagenomi, Beam Therapeutics, Prime Medicine, Epicrispr Bio, and Scribe Therapeutics, this meeting provided you with the critical learnings needed to optimize safety and durability, while building a robust clinical strategy to fast-track best-in-class therapeutics to more patients in need.